
- Telehealth Visits
- Insurance plan information

Tiffany Chen, OD
She | Her | HersOptometry- Telehealth Visits
- Insurance plan information



Tiffany Chen, OD
She | Her | HersOptometry- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Tiffany Chen is an optometrist who provides primary eye care, including for patients with unclear vision due to refractive errors, such as nearsightedness, farsightedness and astigmatism. She also manages eye conditions, such as dry eyes, cataracts, glaucoma, diabetic retinopathy (damage to the retina's blood vessels due to diabetes) and macular degeneration (vision loss caused by retinal deterioration). She has a special interest in treating corneal disorders and anterior segment disorders (conditions affecting the front structures of the eye). Her holistic approach to patient care aims to support overall well-being by treating the entire person rather than only the condition. Paying attention to detail enables her to effectively treat as well as educate her patients about their eye health.
Chen earned her doctor of optometry degree and master's degree in vision science at the SUNY (State University of New York) College of Optometry. She completed a residency in ocular disease and primary eye care at UCSF.
Outside of work, Chen enjoys hiking, traveling, and spending time with family and friends.
Education & training
Residency
- Ocular Disease, University of CA at San Francisco School of Med
Degree
- OD, SUNY College of Optometry
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%224739%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224739%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.